ABBV logo

AbbVie (ABBV) Total Expenses

Annual Total Expenses

$40.78 B
+$1.54 B+3.93%

31 December 2023

ABBV Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$10.55 B
+$1.02 B+10.71%

30 September 2024

ABBV Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABBV Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.9%-9.4%
3 y3 years+23.3%+5.1%
5 y5 years+57.2%+79.9%

ABBV Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+23.3%-9.4%+19.6%
5 y5 yearsat high+105.0%-9.4%+122.1%
alltimeall timeat high+347.6%-9.4%+285.2%

AbbVie Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$10.55 B(+10.7%)
June 2024
-
$9.53 B(+1.9%)
Mar 2024
-
$9.35 B(-15.8%)
Dec 2023
$40.78 B(+3.9%)
$11.11 B(-4.6%)
Sept 2023
-
$11.65 B(+28.4%)
June 2023
-
$9.07 B(-2.5%)
Mar 2023
-
$9.31 B(-3.2%)
Dec 2022
$39.24 B(+5.6%)
$9.62 B(-5.8%)
Sept 2022
-
$10.21 B(-9.6%)
June 2022
-
$11.29 B(+28.0%)
Mar 2022
-
$8.82 B(-10.1%)
Dec 2021
$37.15 B(+12.4%)
$9.81 B(-2.2%)
Sept 2021
-
$10.04 B(+5.4%)
June 2021
-
$9.52 B(+6.9%)
Mar 2021
-
$8.91 B(-11.9%)
Dec 2020
$33.06 B(+66.2%)
$10.11 B(+4.7%)
Sept 2020
-
$9.65 B(-0.3%)
June 2020
-
$9.67 B(+92.8%)
Mar 2020
-
$5.02 B(+5.6%)
Dec 2019
$19.90 B(-23.3%)
$4.75 B(-19.0%)
Sept 2019
-
$5.86 B(+20.7%)
June 2019
-
$4.86 B(+0.8%)
Mar 2019
-
$4.82 B(-55.2%)
Dec 2018
$25.95 B(+41.4%)
$10.75 B(+111.7%)
Sept 2018
-
$5.08 B(-8.0%)
June 2018
-
$5.52 B(+9.6%)
Mar 2018
-
$5.03 B(-15.5%)
Dec 2017
$18.34 B
$5.96 B(+38.5%)
DateAnnualQuarterly
Sept 2017
-
$4.30 B(+0.4%)
June 2017
-
$4.28 B(+3.7%)
Mar 2017
-
$4.13 B(-7.8%)
Dec 2016
$16.10 B(+6.1%)
$4.48 B(+10.1%)
Sept 2016
-
$4.07 B(+0.1%)
June 2016
-
$4.07 B(+10.5%)
Mar 2016
-
$3.68 B(-14.2%)
Dec 2015
$15.17 B(-6.3%)
$4.29 B(+5.6%)
Sept 2015
-
$4.06 B(+12.0%)
June 2015
-
$3.62 B(+8.1%)
Mar 2015
-
$3.35 B(-42.8%)
Dec 2014
$16.20 B(+26.7%)
$5.87 B(+44.5%)
Sept 2014
-
$4.06 B(+19.0%)
June 2014
-
$3.41 B(+6.2%)
Mar 2014
-
$3.21 B(-10.2%)
Dec 2013
$12.79 B(+4.2%)
$3.58 B(+8.8%)
Sept 2013
-
$3.29 B(+1.5%)
June 2013
-
$3.24 B(+7.1%)
Mar 2013
-
$3.02 B(-10.7%)
Dec 2012
$12.28 B(-6.7%)
$3.38 B(+16.2%)
Sept 2012
-
$2.91 B(-5.2%)
June 2012
-
$3.07 B(-3.9%)
Mar 2012
-
$3.19 B(-15.0%)
Dec 2011
$13.15 B(+24.0%)
$3.76 B(-13.7%)
Sept 2011
-
$4.36 B(+59.1%)
June 2011
-
$2.74 B(-7.9%)
Mar 2011
-
$2.97 B
Dec 2010
$10.61 B(+16.4%)
-
Dec 2009
$9.11 B
-

FAQ

  • What is AbbVie annual total expenses?
  • What is the all time high annual total expenses for AbbVie?
  • What is AbbVie annual total expenses year-on-year change?
  • What is AbbVie quarterly total expenses?
  • What is the all time high quarterly total expenses for AbbVie?
  • What is AbbVie quarterly total expenses year-on-year change?

What is AbbVie annual total expenses?

The current annual total expenses of ABBV is $40.78 B

What is the all time high annual total expenses for AbbVie?

AbbVie all-time high annual total expenses is $40.78 B

What is AbbVie annual total expenses year-on-year change?

Over the past year, ABBV annual total expenses has changed by +$1.54 B (+3.93%)

What is AbbVie quarterly total expenses?

The current quarterly total expenses of ABBV is $10.55 B

What is the all time high quarterly total expenses for AbbVie?

AbbVie all-time high quarterly total expenses is $11.65 B

What is AbbVie quarterly total expenses year-on-year change?

Over the past year, ABBV quarterly total expenses has changed by -$1.10 B (-9.44%)